KR100948532B1
(ko)
|
2001-11-07 |
2010-03-23 |
넥타르 테라퓨틱스 |
분지형 중합체 및 그의 공액체
|
ES2315526T3
(es)
*
|
2002-09-09 |
2009-04-01 |
Nektar Therapeutics Al, Corporation |
Metodo para preparar derivados polimericos solubles en agua que llevan un acido carboxilico terminal.
|
JP4764630B2
(ja)
*
|
2002-09-09 |
2011-09-07 |
ネクター セラピューティックス |
水溶性ポリマーアルカナール
|
EP1591467A1
(en)
*
|
2002-09-09 |
2005-11-02 |
Nektar Therapeutics Al, Corporation |
Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone
|
AU2003295432A1
(en)
|
2002-11-12 |
2004-06-03 |
Enzon Pharmaceuticals, Inc. |
Prodrugs of vancomycin with hydrolysis resistant polymer linkers
|
WO2004044222A2
(en)
|
2002-11-12 |
2004-05-27 |
Enzon Pharmaceuticals, Inc. |
Polymeric prodrugs of vancomycin
|
GB0301014D0
(en)
*
|
2003-01-16 |
2003-02-19 |
Biocompatibles Ltd |
Conjugation reactions
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
CA2517145C
(en)
*
|
2003-03-05 |
2017-08-01 |
Halozyme, Inc. |
Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof
|
US20090123367A1
(en)
*
|
2003-03-05 |
2009-05-14 |
Delfmems |
Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
|
US7871607B2
(en)
*
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
US20040249119A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Fox Martin Edward |
Novel mPEG propionaldehyde precursor
|
GB0314472D0
(en)
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
JP2007501811A
(ja)
*
|
2003-08-08 |
2007-02-01 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。
|
WO2005035727A2
(en)
*
|
2003-10-09 |
2005-04-21 |
Ambrx, Inc. |
Polymer derivatives
|
JP5268255B2
(ja)
*
|
2003-11-21 |
2013-08-21 |
エイエヌピー テクノロジーズ, インコーポレイテッド |
非対称分岐ポリマー抱合体およびマイクロアレイアッセイ
|
AU2005211385B2
(en)
|
2004-02-02 |
2008-12-11 |
Ambrx, Inc. |
Modified human growth hormone polypeptides and their uses
|
US8562965B2
(en)
|
2004-05-03 |
2013-10-22 |
Nektar Therapeutics |
Polymer derivatives comprising an acetal or ketal branching point
|
WO2006009901A2
(en)
*
|
2004-06-18 |
2006-01-26 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
MXPA06015234A
(es)
*
|
2004-06-30 |
2007-11-22 |
Nektar Therapeutics Al Corp |
Conjugados de fraccion polimero-factor ix.
|
WO2006019904A1
(en)
|
2004-07-14 |
2006-02-23 |
University Of Utha Research Foundation |
Netrin-related compositions and uses
|
MX2007000568A
(es)
*
|
2004-07-16 |
2007-03-30 |
Nektar Therapeutics Al Corp |
Conjugados de una fraccion gm-csf y un polimero.
|
US7638299B2
(en)
*
|
2004-07-21 |
2009-12-29 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
JP4920593B2
(ja)
*
|
2004-10-25 |
2012-04-18 |
インテザイン テクノロジーズ, インコーポレイテッド |
ヘテロ二官能性ポリ(エチレングリコール)およびそれらの使用
|
MX2007007591A
(es)
|
2004-12-22 |
2007-07-25 |
Ambrx Inc |
Metodos para expresion y purificacion de hormona de crecimiento humano recombinante.
|
EP1836298B1
(en)
|
2004-12-22 |
2012-01-18 |
Ambrx, Inc. |
COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
|
ATE542920T1
(de)
*
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Modifiziertes menschliches wachstumshormon
|
MX2007007590A
(es)
|
2004-12-22 |
2007-12-10 |
Ambrx Inc |
Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos.
|
US7816320B2
(en)
|
2004-12-22 |
2010-10-19 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
|
CN101163506B
(zh)
|
2004-12-27 |
2012-09-26 |
巴克斯特国际公司 |
聚合物-von Willebrand因子偶联物
|
WO2006094530A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Siegfried Ltd. |
Di-polymer protein conjugates and processes for their preparation
|
WO2006102484A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Anp Technologies, Inc. |
Symmetrically branched polymer conjugates and microarray assays
|
US20060233740A1
(en)
*
|
2005-03-23 |
2006-10-19 |
Bossard Mary J |
Conjugates of an hGH moiety and a polymer
|
US8563329B2
(en)
|
2005-05-02 |
2013-10-22 |
Anp Technologies, Inc. |
Polymer conjugate enhanced bioassays
|
CN103030690A
(zh)
|
2005-06-03 |
2013-04-10 |
Ambrx公司 |
经改良人类干扰素分子和其用途
|
EP2412744B1
(en)
|
2005-07-18 |
2014-01-22 |
Nektar Therapeutics |
Method for preparing branched functionalised polymers using branched polyol cores
|
JP2007112924A
(ja)
*
|
2005-10-21 |
2007-05-10 |
National Institute For Materials Science |
高分子架橋剤及びこの架橋剤を用いたリポソーム又は細胞の架橋体
|
US20090018029A1
(en)
|
2005-11-16 |
2009-01-15 |
Ambrx, Inc. |
Methods and Compositions Comprising Non-Natural Amino Acids
|
CU23556A1
(es)
*
|
2005-11-30 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico
|
EP1960447A4
(en)
|
2005-12-08 |
2010-12-01 |
Tyco Healthcare |
BIOCOMPATIBLE SURGICAL COMPOSITIONS
|
CN105384807A
(zh)
*
|
2005-12-14 |
2016-03-09 |
Ambrx公司 |
含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
|
JP5096363B2
(ja)
*
|
2005-12-16 |
2012-12-12 |
ネクター セラピューティックス |
Glp−1のポリマ複合体
|
US20100012883A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Outlast Technologies, Inc. |
Functional Polymeric Phase Change Materials
|
US20070173154A1
(en)
*
|
2006-01-26 |
2007-07-26 |
Outlast Technologies, Inc. |
Coated articles formed of microcapsules with reactive functional groups
|
US9234059B2
(en)
*
|
2008-07-16 |
2016-01-12 |
Outlast Technologies, LLC |
Articles containing functional polymeric phase change materials and methods of manufacturing the same
|
US8404341B2
(en)
|
2006-01-26 |
2013-03-26 |
Outlast Technologies, LLC |
Microcapsules and other containment structures for articles incorporating functional polymeric phase change materials
|
US20100016513A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Outlast Technologies, Inc. |
Functional Polymeric Phase Change Materials and Methods of Manufacturing the Same
|
JP5528710B2
(ja)
*
|
2006-02-28 |
2014-06-25 |
オリガシス コーポレイション |
アクリロイルオキシエチルホスホリルコリン含有ポリマー抱合体及びその製法
|
EP1834963A1
(en)
*
|
2006-03-13 |
2007-09-19 |
Siegfried Ltd. |
Di-polymer protein conjugates and processes for their preparation
|
BRPI0708832A2
(pt)
|
2006-03-31 |
2011-06-14 |
Baxter Int |
construÇço proteinÁcea
|
US7985839B2
(en)
*
|
2006-03-31 |
2011-07-26 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
US7645860B2
(en)
*
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
US7982010B2
(en)
*
|
2006-03-31 |
2011-07-19 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
CA2650035C
(en)
|
2006-04-27 |
2015-02-03 |
Intezyne Technologies, Inc. |
Poly (ethylene glycol) containing chemically disparate endgroups
|
EP2018437A2
(en)
*
|
2006-05-02 |
2009-01-28 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
US20080096819A1
(en)
*
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
US8232360B2
(en)
|
2006-07-17 |
2012-07-31 |
Research Foundation Of State University Of N.Y. |
Stereoregular ROMP polymers
|
AU2007292903B2
(en)
|
2006-09-08 |
2012-03-29 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
SG174781A1
(en)
|
2006-09-08 |
2011-10-28 |
Ambrx Inc |
Hybrid suppressor trna for vertebrate cells
|
US8367065B2
(en)
*
|
2006-09-15 |
2013-02-05 |
Enzon Pharmaceuticals, Inc. |
Targeted polymeric prodrugs containing multifunctional linkers
|
CA2662973A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Enzon Pharmaceuticals, Inc. |
Lysine-based polymeric linkers
|
CA2670618C
(en)
|
2006-12-15 |
2016-10-04 |
Baxter International Inc. |
Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life
|
US20140011964A1
(en)
*
|
2007-02-28 |
2014-01-09 |
Serina Therapeutics, Inc. |
Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
|
KR101476472B1
(ko)
|
2007-03-30 |
2015-01-05 |
암브룩스, 인코포레이티드 |
변형된 fgf-21 폴리펩티드 및 그 용도
|
CA2685596A1
(en)
|
2007-05-02 |
2008-11-13 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
BRPI0721948A2
(pt)
*
|
2007-08-20 |
2014-04-08 |
Enzon Pharmaceuticals Inc |
Ligantes poliméricos contendo frações dissulfeto de piridila
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
NZ584825A
(en)
|
2007-11-20 |
2013-03-28 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
US9345809B2
(en)
*
|
2007-11-28 |
2016-05-24 |
Fziomed, Inc. |
Carboxymethylcellulose polyethylene glycol compositions for medical uses
|
JP5702150B2
(ja)
|
2008-02-08 |
2015-04-15 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾されているレプチンポリペプチドおよびそれらの使用
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
MX2010010953A
(es)
*
|
2008-04-03 |
2011-04-21 |
Biosteed Gene Expression Tech Co Ltd |
Hormona de crecimiento modificada con glicol de polietileno de doble cadena, metodo de preparacion y aplicación del a misma.
|
AU2009236635B2
(en)
|
2008-04-14 |
2014-02-13 |
Halozyme, Inc. |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
|
TWI394580B
(zh)
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
US8476404B1
(en)
*
|
2008-07-04 |
2013-07-02 |
Bhalchandra Shripad Lele |
Selectively functionalized polyhydric compounds
|
US20100015430A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Outlast Technologies, Inc. |
Heat Regulating Article With Moisture Enhanced Temperature Control
|
US8221910B2
(en)
|
2008-07-16 |
2012-07-17 |
Outlast Technologies, LLC |
Thermal regulating building materials and other construction components containing polymeric phase change materials
|
JP5680534B2
(ja)
|
2008-07-23 |
2015-03-04 |
イーライ リリー アンド カンパニー |
修飾されているウシg−csfポリペプチドおよびそれらの使用
|
CA2732508C
(en)
|
2008-08-11 |
2016-03-15 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
WO2010033205A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of v681-like peptides
|
US20110171166A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of osteocalcin peptides
|
US20110171164A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of glp-2-like peptides
|
US20110165112A1
(en)
*
|
2008-09-19 |
2011-07-07 |
Nektar Therapeutics |
Polymer conjugates of c-peptides
|
EP2344199A1
(en)
*
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Polymer conjugates of thymosin alpha 1 peptides
|
WO2010033221A1
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of protegrin peptides
|
US20110206633A1
(en)
*
|
2008-09-19 |
2011-08-25 |
Nektar Therapectics |
Polymer conjugates of cd-np peptides
|
WO2010033215A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of aod-like peptides
|
EP2334337A1
(en)
*
|
2008-09-19 |
2011-06-22 |
Nektar Therapeutics |
Polymer conjugates of opioid growth factor peptides
|
WO2010033224A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Polymer conjugates of kiss1 peptides
|
US20110171163A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of ziconotide peptides
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
WO2010033220A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Modified therapeutics peptides, methods of their preparation and use
|
AU2009296267B2
(en)
|
2008-09-26 |
2013-10-31 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
PL2342223T3
(pl)
|
2008-09-26 |
2017-09-29 |
Ambrx, Inc. |
Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
|
JP4966434B2
(ja)
*
|
2008-10-15 |
2012-07-04 |
バクスター・インターナショナル・インコーポレイテッド |
結合抗体の存在下における組換え血液凝固因子のpeg化
|
CN102307993B
(zh)
|
2008-12-09 |
2014-06-25 |
哈洛齐梅公司 |
延长的可溶性ph20多肽及其用途
|
CN101870728A
(zh)
|
2009-04-23 |
2010-10-27 |
派格生物医药(苏州)有限公司 |
新型Exendin变体及其缀合物
|
TW201042257A
(en)
*
|
2009-05-26 |
2010-12-01 |
Baxter Int |
Detection of antibody that binds to water soluble polymer-modified polypeptides
|
ES2597954T3
(es)
|
2009-07-27 |
2017-01-24 |
Baxalta GmbH |
Conjugados de proteína de la coagulación sanguínea
|
KR101912335B1
(ko)
|
2009-07-27 |
2018-10-26 |
리폭센 테크놀로지즈 리미티드 |
비혈액 응고 단백질의 글리코폴리시알화
|
US8809501B2
(en)
|
2009-07-27 |
2014-08-19 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
NZ623810A
(en)
|
2009-07-27 |
2015-10-30 |
Lipoxen Technologies Ltd |
Glycopolysialylation of non-blood coagulation proteins
|
US8642737B2
(en)
|
2010-07-26 |
2014-02-04 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
CA2774053C
(en)
|
2009-09-17 |
2015-04-28 |
Baxter Healthcare, S.A. |
Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
|
US20110081398A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Tyco Healthcare Group Lp |
Multi-mechanism surgical compositions
|
US8968785B2
(en)
*
|
2009-10-02 |
2015-03-03 |
Covidien Lp |
Surgical compositions
|
US20110081701A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Timothy Sargeant |
Surgical compositions
|
US8697648B2
(en)
*
|
2009-10-20 |
2014-04-15 |
Georgia State University Research Foundation, Inc. |
Protein agent for diabetes treatment and β cell imaging
|
WO2011081915A2
(en)
*
|
2009-12-15 |
2011-07-07 |
Cebix Inc. |
Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
CN107674121A
(zh)
|
2009-12-21 |
2018-02-09 |
Ambrx 公司 |
经过修饰的牛促生长素多肽和其用途
|
CN104017063A
(zh)
|
2009-12-21 |
2014-09-03 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
JP5914363B2
(ja)
*
|
2010-02-16 |
2016-05-11 |
ノヴォ ノルディスク アー/エス |
低減されたvwf結合を有する因子viii分子
|
KR20130115086A
(ko)
|
2010-05-17 |
2013-10-21 |
세빅스 인코포레이티드 |
페길화된 c-펩티드
|
JP5825507B2
(ja)
*
|
2010-06-25 |
2015-12-02 |
日油株式会社 |
分岐型ヘテロポリエチレングリコール
|
US10040761B2
(en)
*
|
2010-06-25 |
2018-08-07 |
Nof Corporation |
Branched hetero polyethylene glycol and intermediate
|
MX348420B
(es)
|
2010-07-20 |
2017-06-12 |
Halozyme Inc |
Efectos secundarios adversos asociados con la administracion de agentes anti-hialuronano y metodos para mejorar o prevenir los efectos secundarios.
|
MX346271B
(es)
|
2010-07-30 |
2016-07-08 |
Baxalta Inc |
Catalizadores nucleofílicos para enlace de oxima.
|
MX346786B
(es)
|
2010-08-17 |
2017-03-31 |
Ambrx Inc |
Polipeptidos de relaxina modificados y sus usos.
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
US8841382B2
(en)
|
2010-09-01 |
2014-09-23 |
Basf Se |
Hyperbranched polyethers/dendrimers for solubilzation of sparingly soluble active ingredients
|
CN103189409B
(zh)
|
2010-09-01 |
2015-11-25 |
巴斯夫欧洲公司 |
用于增溶微溶性活性成分的两亲物
|
JP6042335B2
(ja)
|
2010-09-15 |
2016-12-14 |
ノヴォ ノルディスク アー/エス |
細胞取込みが低下した第viii因子変異体
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
WO2012054822A1
(en)
|
2010-10-22 |
2012-04-26 |
Nektar Therapeutics |
Pharmacologically active polymer-glp-1 conjugates
|
WO2012083197A1
(en)
|
2010-12-17 |
2012-06-21 |
Nektar Therapeutics |
Water-soluble polymer conjugates of topotecan
|
US10736969B2
(en)
|
2010-12-21 |
2020-08-11 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
|
US10894087B2
(en)
|
2010-12-22 |
2021-01-19 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
BR112013015898A2
(pt)
|
2010-12-22 |
2018-06-26 |
Baxter International Inc. |
derivado de ácido graxo solúvel em água, e, métodos para preparar um derivado de ácido graxo e uma proteína terapêutica conjugada.
|
JP6009457B2
(ja)
|
2010-12-23 |
2016-10-19 |
ネクター セラピューティクス |
ポリマー−デスエチルスニチニブコンジュゲート
|
US9943605B2
(en)
|
2010-12-23 |
2018-04-17 |
Nektar Therapeutics |
Polymer-semaxanib moiety conjugates
|
EP2654799B1
(en)
|
2010-12-23 |
2017-11-08 |
Nektar Therapeutics |
Polymer-sunitinib conjugates
|
ES2634669T3
(es)
|
2011-02-08 |
2017-09-28 |
Halozyme, Inc. |
Composición y formulación lipídica de una enzima de degradación de hialuronano y uso de la misma para el tratamiento de la hiperplasia benigna de próstata
|
US8673448B2
(en)
|
2011-03-04 |
2014-03-18 |
Outlast Technologies Llc |
Articles containing precisely branched functional polymeric phase change materials
|
CN103608399B
(zh)
|
2011-04-06 |
2015-11-25 |
斯蒂潘公司 |
多臂亲水的氨基甲酸乙酯聚合物、制备它们的方法以及使用它们的组合物和方法
|
US20140088021A1
(en)
|
2011-05-27 |
2014-03-27 |
Nektar Therapeutics |
Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
|
EP3412314A1
(en)
|
2011-05-27 |
2018-12-12 |
Baxalta GmbH |
Therapeutic proteins conjugated to polysialic acid and methods of preparing same
|
EA201400030A1
(ru)
|
2011-06-17 |
2014-07-30 |
Галозим, Инк. |
Способ непрерывного подкожного введения инсулина с использованием фермента, разрушающего хиалуронан
|
US20130011378A1
(en)
|
2011-06-17 |
2013-01-10 |
Tzung-Horng Yang |
Stable formulations of a hyaluronan-degrading enzyme
|
US20130071394A1
(en)
|
2011-09-16 |
2013-03-21 |
John K. Troyer |
Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
|
US8846034B2
(en)
|
2011-10-24 |
2014-09-30 |
Halozyme, Inc. |
Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
|
CN104220086A
(zh)
|
2011-11-17 |
2014-12-17 |
塞比克斯股份公司 |
Peg化的c-肽
|
WO2013102144A2
(en)
|
2011-12-30 |
2013-07-04 |
Halozyme, Inc. |
Ph20 polypeptede variants, formulations and uses thereof
|
BR112014024291B1
(pt)
|
2012-03-30 |
2022-07-05 |
The Board Of Regents Of The University Of Oklahoma |
Método para a produção de forma recombinante de um polímero de heparosan com alto peso molecular, uso do referido polímero para aumento de tecido, polinucleotídeo isolado e composição de material biológico compreendendo o referido polímero
|
CA2869460C
(en)
|
2012-04-04 |
2018-05-15 |
Halozyme, Inc. |
Combination therapy with an anti-hyaluronan agent and a tumor-targeted taxane
|
AU2013204754C1
(en)
|
2012-05-16 |
2018-10-11 |
Takeda Pharmaceutical Company Limited |
Nucleophilic Catalysts for Oxime Linkage
|
AU2013270684B2
(en)
|
2012-06-08 |
2018-04-19 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
DK2863955T3
(en)
|
2012-06-26 |
2017-01-23 |
Sutro Biopharma Inc |
MODIFIED FC PROTEINS, INCLUDING LOCATION-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES THEREOF, METHODS OF PRODUCING ITS AND PROCEDURES FOR USE THEREOF
|
EP4074728A1
(en)
|
2012-08-31 |
2022-10-19 |
Sutro Biopharma, Inc. |
Modified peptides comprising an azido group
|
US9278124B2
(en)
|
2012-10-16 |
2016-03-08 |
Halozyme, Inc. |
Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
|
DK2947111T3
(en)
*
|
2013-01-17 |
2018-05-07 |
Xiamen Sinopeg Biotech Co Ltd |
MONOFUNCTIONAL BRANCHED POLYETHYLENE LYCOL AND BIORELATED SUBSTANCE MODIFIED BY SAME
|
US9272075B2
(en)
|
2013-02-04 |
2016-03-01 |
W.L. Gore & Associates, Inc. |
Coating for substrate
|
ES2692150T3
(es)
|
2013-02-04 |
2018-11-30 |
W.L. Gore & Associates, Inc. |
Revestimiento para sustrato
|
TW201534726A
(zh)
|
2013-07-03 |
2015-09-16 |
Halozyme Inc |
熱穩定ph20玻尿酸酶變異體及其用途
|
ES2865473T3
(es)
|
2013-07-10 |
2021-10-15 |
Sutro Biopharma Inc |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
JP6463361B2
(ja)
|
2013-09-08 |
2019-01-30 |
コディアック サイエンシーズ インコーポレイテッドKodiak Sciences Inc. |
第viii因子両性イオンポリマーコンジュゲート
|
WO2015054658A1
(en)
|
2013-10-11 |
2015-04-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
HUE051389T2
(hu)
|
2013-10-15 |
2021-03-01 |
Seagen Inc |
Pegilezett gyógyszer-linkerek ligandum-gyógyszer konjugátum javított farmakokinetikájához
|
WO2015104374A1
(en)
*
|
2014-01-10 |
2015-07-16 |
Eth Zurich |
Polyethylene glycol substituted acyl borates
|
JP6106103B2
(ja)
|
2014-01-16 |
2017-03-29 |
信越化学工業株式会社 |
末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法、並びにこれに用いる新規なアセタール基含有アルコール化合物及びそのアルカリ金属塩
|
JP6106104B2
(ja)
|
2014-01-16 |
2017-03-29 |
信越化学工業株式会社 |
末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
CN104109238A
(zh)
*
|
2014-07-13 |
2014-10-22 |
成都市绿科华通科技有限公司 |
六方孔状功能聚乙二醇的制备方法
|
PL3186281T3
(pl)
|
2014-08-28 |
2019-10-31 |
Halozyme Inc |
Terapia skojarzona enzymem rozkładającym hialuronian i inhibitorem punktu kontrolnego odpowiedzi immunologicznej
|
PL3207130T3
(pl)
|
2014-10-14 |
2020-02-28 |
Halozyme, Inc. |
Kompozycje deaminazy adenozyny 2 (ada2), jej warianty i sposoby ich zastosowania
|
KR101585795B1
(ko)
*
|
2014-10-14 |
2016-01-15 |
주식회사 파이토켐텍 |
활성 성분으로 디에칠렌글라이콜모노벤질에텔을 함유하는 보존제 조성물
|
JP6849590B2
(ja)
|
2014-10-17 |
2021-03-24 |
コディアック サイエンシーズ インコーポレイテッドKodiak Sciences Inc. |
ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート
|
KR102637699B1
(ko)
|
2014-10-24 |
2024-02-19 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
CA2968301C
(en)
|
2014-11-19 |
2023-05-16 |
NZP UK Limited |
5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal fxr modulators
|
WO2016079520A1
(en)
|
2014-11-19 |
2016-05-26 |
Dextra Laboratories Limited |
6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
|
CA2968309A1
(en)
|
2014-11-19 |
2016-05-26 |
NZP UK Limited |
6-alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the production of steroidal fxr modulators
|
TWI686401B
(zh)
|
2014-11-19 |
2020-03-01 |
英商Nzp英國有限公司 |
化合物(三)
|
US10431858B2
(en)
|
2015-02-04 |
2019-10-01 |
Global Web Horizons, Llc |
Systems, structures and materials for electrochemical device thermal management
|
US10003053B2
(en)
|
2015-02-04 |
2018-06-19 |
Global Web Horizons, Llc |
Systems, structures and materials for electrochemical device thermal management
|
US10120948B2
(en)
|
2015-10-13 |
2018-11-06 |
Google Llc |
Providing notifications based on geofencing search results
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
US11229708B2
(en)
|
2015-12-04 |
2022-01-25 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
CN106905120B
(zh)
*
|
2015-12-21 |
2020-04-28 |
北京键凯科技股份有限公司 |
Y型多缩乙二醇衍生物及其制备方法
|
KR20180104635A
(ko)
|
2015-12-30 |
2018-09-21 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
EP3407917A1
(en)
|
2016-01-27 |
2018-12-05 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
SG11201807827VA
(en)
|
2016-03-25 |
2018-10-30 |
Seattle Genetics Inc |
Process for the preparation of pegylated drug-linkers and intermediates thereof
|
GB201608777D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Compounds
|
GB201608776D0
(en)
|
2016-05-18 |
2016-06-29 |
Dextra Lab Ltd |
Methods and compounds
|
CN109843972B
(zh)
|
2016-10-07 |
2021-08-13 |
国立大学法人东京工业大学 |
分支型异单分散聚乙二醇及其制造方法和其缀合物
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
SG11201907209QA
(en)
|
2017-02-08 |
2019-09-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
JP2020512312A
(ja)
|
2017-03-24 |
2020-04-23 |
シアトル ジェネティックス, インコーポレイテッド |
グルクロニド薬物−リンカーの調製のためのプロセスおよびその中間体
|
US10781435B2
(en)
|
2017-06-22 |
2020-09-22 |
Catalyst Biosciences, Inc. |
Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
|
AU2018300069A1
(en)
|
2017-07-11 |
2020-02-27 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
US20200181220A1
(en)
|
2017-08-03 |
2020-06-11 |
Synthorx, Inc. |
Cytokine conjugates for the treatment of proliferative and infectious diseases
|
US10596270B2
(en)
|
2017-09-18 |
2020-03-24 |
Sutro Biopharma, Inc. |
Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
PL3849614T3
(pl)
|
2018-09-11 |
2024-04-22 |
Ambrx, Inc. |
Koniugaty polipeptydu interleukiny-2 i ich zastosowania
|
JP2022500454A
(ja)
|
2018-09-17 |
2022-01-04 |
ストロ バイオファーマ インコーポレーテッド |
抗葉酸受容体抗体コンジュゲートによる併用療法
|
CN110964116A
(zh)
|
2018-09-26 |
2020-04-07 |
北京辅仁瑞辉生物医药研究院有限公司 |
GLP1-Fc融合蛋白及其缀合物
|
CN113366015A
(zh)
|
2018-10-19 |
2021-09-07 |
Ambrx公司 |
白细胞介素-10多肽缀合物、其二聚体及其用途
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
CN113661239A
(zh)
|
2018-12-28 |
2021-11-16 |
催化剂生物科学公司 |
经修饰的尿激酶型纤溶酶原激活物多肽和使用方法
|
CN114949240A
(zh)
|
2019-02-06 |
2022-08-30 |
新索思股份有限公司 |
Il-2缀合物及其使用方法
|
EP3923991A1
(en)
|
2019-02-12 |
2021-12-22 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
US20220362394A1
(en)
|
2019-05-03 |
2022-11-17 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
CN114269749A
(zh)
|
2019-06-10 |
2022-04-01 |
苏特罗生物制药公司 |
5H-吡咯并[3,2-d]嘧啶-2,4-二氨基化合物及其抗体偶联物
|
CN114746420A
(zh)
|
2019-06-17 |
2022-07-12 |
苏特罗生物制药公司 |
用于癌症治疗和诊断的作为Toll样受体(TLR)7/8激动剂的1-(4-(氨基甲基)苄基)-2-丁基-2H-吡唑并[3,4-c]喹啉-4-胺衍生物及相关化合物以及其抗体药物偶联物
|
CN112175088B
(zh)
|
2019-07-02 |
2023-03-28 |
江苏晟斯生物制药有限公司 |
改进的fix融合蛋白、缀合物及其应用
|
JP2022547078A
(ja)
|
2019-09-10 |
2022-11-10 |
シンソークス, インコーポレイテッド |
Il-2コンジュゲートおよび自己免疫疾患を治療するための使用方法
|
CN114786731A
(zh)
|
2019-10-10 |
2022-07-22 |
科达制药股份有限公司 |
治疗眼部病症的方法
|
JP2022554272A
(ja)
|
2019-11-04 |
2022-12-28 |
シンソークス, インコーポレイテッド |
インターロイキン10コンジュゲートおよびその使用
|
US20230095053A1
(en)
|
2020-03-03 |
2023-03-30 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
|
AU2021233909A1
(en)
|
2020-03-11 |
2022-09-29 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
EP3954393A1
(en)
|
2020-08-13 |
2022-02-16 |
Bioasis Technologies Inc. |
Combination therapies for delivery across the blood brain barrier
|
KR20230073200A
(ko)
|
2020-08-20 |
2023-05-25 |
암브룩스, 인코포레이티드 |
항체-tlr 작용제 접합체, 그 방법 및 용도
|
TW202228784A
(zh)
|
2020-09-23 |
2022-08-01 |
奧地利商艾柏力維亞生技有限公司 |
用以於一患者中螯合非預期的抗peg抗體的化合物
|
WO2022103983A2
(en)
|
2020-11-11 |
2022-05-19 |
Sutro Biopharma, Inc. |
Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
|
JP2024512775A
(ja)
|
2021-04-03 |
2024-03-19 |
アンブルックス,インコーポレイテッド |
抗her2抗体薬物コンジュゲート及びその使用
|
AR125490A1
(es)
|
2021-04-30 |
2023-07-19 |
Celgene Corp |
Terapias de combinación que utilizan un anticuerpo anti-bcma conjugado a fármaco (adc) en combinación con un inhibidor de gamma secretasa (gsi)
|
US20240091365A1
(en)
|
2022-06-27 |
2024-03-21 |
Sutro Biopharma, Inc. |
Beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof
|
US20240058465A1
(en)
|
2022-06-30 |
2024-02-22 |
Sutro Biopharma, Inc. |
Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates
|
WO2024015229A1
(en)
|
2022-07-15 |
2024-01-18 |
Sutro Biopharma, Inc. |
Protease/enzyme cleavable linker-payloads and protein conjugates
|
WO2024044780A1
(en)
|
2022-08-26 |
2024-02-29 |
Sutro Biopharma, Inc. |
Interleukin-18 variants and uses thereof
|
CN115873231A
(zh)
*
|
2022-12-17 |
2023-03-31 |
华南理工大学 |
一种聚乙二醇修饰的氨基糖苷类分子及其制备方法和应用
|